Pharmacological evaluation of a potential psychotherapeutic agent: cyprolidol, a pyridylcyclopropane derivative.
D000435:Alcoholic Intoxication; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D003521:Cyclopropanes / Q000494:pharmacology*; D003913:Dextroamphetamine / Q000494:pharmacology; D000882:Haplorhini; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D008995:Monoamine Oxidase; D009020:Morphine / Q000494:pharmacology; D009048:Motor Skills / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects
D003521:Cyclopropanes; D009020:Morphine; D012110:Reserpine; D008995:Monoamine Oxidase; D003913:Dextroamphetamine; D002746:Chlorpromazine